Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension

Circulation Journal

Volumn 76, Issue 2, 2012, Pages 485-488

  Sugimura, Koichiro ^a   Fukumoto, Yoshihiro ^a   Satoh, Kimio ^a   Nochioka, Kotaro ^a   Miura, Yutaka ^a   Aoki, Tatsuo ^a   Tatebe, Shunsuke ^a   Miyamichi Yamamoto, Saori ^a   Shimokawa, Hiroaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic thromboembolic pulmonary hypertension; Optical coherence tomography; Percutaneous transluminal pulmonary angioplasty

Indexed keywords

BERAPROST; BOSENTAN; BRAIN NATRIURETIC PEPTIDE; PROSTACYCLIN; SILDENAFIL; VASODILATOR AGENT;

ADULT; ANGIOGRAPHY; ARTICLE; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CONTROLLED STUDY; FEMALE; HEART INDEX; HEART RIGHT ATRIUM PRESSURE; HEMOPTYSIS; HUMAN; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROGNOSIS; PROSPECTIVE STUDY;

AGED; ANGIOPLASTY; ANTIHYPERTENSIVE AGENTS; CHRONIC DISEASE; COMBINED MODALITY THERAPY; EPOPROSTENOL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PIPERAZINES; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY CIRCULATION; PURINES; SULFONAMIDES; SULFONES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 84856239291     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1217     Document Type: Article

References (9)

1. Lang IM, Klepetko W. Chronic thromboembolic pulmonary hypertension: An updated review. Curr Opin Cardiol 2008; 23: 555-559.
2. Yoshimi S, Tanabe N, Masuda M, Sakao S, Uruma T, Shimizu H, et al. Survival and quality of life for patients with peripheral type chronic thromboembolic pulmonary hypertension. Circ J 2008; 72: 958-965.
3. Miura Y, Fukumoto Y, Sugimura K, Oikawa M, Nakano M, Tatebe S, et al. Identification of new prognostic factors of pulmonary hypertension. Circ J 2010; 74: 1965-1971.
4. Piazza G, Goldhaber SZ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2011; 364: 351-360.
5. Fukumoto Y, Shimokawa H. Recent progress in the management of pulmonary hypertension. Circ J 2011; 75: 1801-1810.
6. Do e Z, Fukumoto Y, Takaki A, Tawara S, Ohashi J, Nakano M, et al. Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension. Circ J 2009; 73: 1731-1739.
7. Feinstein JA, Goldhaber SZ, Lock JE, Ferndandes SM, Landzberg MJ. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation 2001; 103: 10-13.
8. Tatebe S, Fukumoto Y, Sugimura K, Nakano M, Miyamichi S, Satoh K, et al. Optical coherence tomography as a novel diagnostic tool for distal type chronic thromboembolic pulmonary hypertension. Circ J 2010; 74: 1742-1744.
9. Condliffe R, Kiely DG, Gibbs JS, Corris PA, Peacock AJ, Jenkins DP, et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2008; 177: 1122-1127.